P.3.10 Aβ Affitopes as active vaccines in the treatment of Alzheimer's diasease: preliminary results of two phase I studies (original) (raw)

AD Vaccines: Conclusions and Future Directions

Thomas Wisniewski

CNS & Neurological Disorders - Drug Targets, 2009

View PDFchevron_right

Developing novel immunogens for a safe and effective Alzheimer's disease vaccine

Progress in Brain Research, 2009

View PDFchevron_right

The generation and characterization of potentially therapeutic Aβ antibodies in mice: differences according to strain and immunization protocol

Vaccine, 2002

View PDFchevron_right

A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer’s Disease

Madepalli Lakshmana, Carmen Vigo

BioMed Research International, 2015

View PDFchevron_right

Amyloid-β Immunotherapy for Alzheimers Disease

Cns & Neurological Disorders-drug Targets, 2010

View PDFchevron_right

Alzheimer's Disease Peptide Epitope Vaccine Reduces Insoluble But Not Soluble/Oligomeric A Species in Amyloid Precursor Protein Transgenic Mice

Irina Petrushina, Hayk Davtyan, Grigor Mamikonyan

Journal of Neuroscience, 2007

View PDFchevron_right

Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies

Tohoku Journal of Experimental Medicine, 2010

View PDFchevron_right

Vaccine Development to Treat Alzheimer’s Disease Neuropathology in APP/PS1 Transgenic Mice

International Journal of Alzheimer's Disease, 2012

View PDFchevron_right

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-í µí»½ Vaccine

Gjumrakch Aliev, Carmen Vigo

BioMed Research International

View PDFchevron_right

An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β1

Journal of Alzheimer's Disease, 2020

View PDFchevron_right

Rejecting the Alzheimer's disease vaccine development for the wrong reasons

Drug Discovery Today, 2017

View PDFchevron_right

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Thomas Wisniewski

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010

View PDFchevron_right

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid β peptides

BMC Neuroscience, 2008

View PDFchevron_right

A Vaccine Kit for Prevention and Therapy of Alzheimer’s Disease in a Transgenic Mouse Model

Ramón Cacabelos

Journal of Exploratory Research in Pharmacology

View PDFchevron_right

Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer’s Disease

Irina Petrushina

Molecular Therapy, 2017

View PDFchevron_right

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine

BioMed Research International, 2013

View PDFchevron_right

Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine

Research, 2019

View PDFchevron_right

Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice

Neurochemical research, 2003

View PDFchevron_right

MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013

View PDFchevron_right

Immunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines

Kanitha Patarakul

Human Vaccines & Immunotherapeutics, 2014

View PDFchevron_right

Immunotherapy for Alzheimer's disease

Thomas Wisniewski

Biochemical Pharmacology, 2014

View PDFchevron_right

Immune shaping and the development of Alzheimer's disease vaccines

Howard Federoff

2005

View PDFchevron_right

Amyloid-β immunisation for Alzheimer's disease

Thomas Wisniewski

The Lancet Neurology, 2008

View PDFchevron_right

Immunization therapy in Alzheimer's disease

Expert Review of Neurotherapeutics, 2006

View PDFchevron_right

Low Concentrations of Anti-Aβ Antibodies Generated in Tg2576 Mice by DNA Epitope Vaccine Fused with 3C3d Molecular Adjuvant Do Not Affect AD Pathology

Human Gene Therapy, 2010

View PDFchevron_right

Amyloid-β Immunotherapy on Alzheimer disease: Prevention and Therapeutic Target

Opeyemi Adeloye

Journal of dermatology research and review, 2020

View PDFchevron_right

Alzheimer's disease: is a vaccine possible?

Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.], 2014

View PDFchevron_right

Prototype Alzheimer's Disease Vaccine Using the Immunodominant B Cell Epitope from -Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide

Irina Petrushina

The Journal of Immunology, 2005

View PDFchevron_right

Developing therapeutic vaccines against Alzheimer's disease

Thomas Wisniewski

Expert review of vaccines, 2015

View PDFchevron_right

Is passive immunization for Alzheimer's disease ‘alive and well’ or ‘dead and buried’?

Expert Opinion on Biological Therapy, 2009

View PDFchevron_right

Antibody therapy for Alzheimer's disease

Clinical Genetics, 1999

View PDFchevron_right